[
    [
        {
            "time": "",
            "original_text": "首款PD-1肺癌免疫药物7个月获批，美国一年疗售价百万",
            "features": {
                "keywords": [
                    "PD-1",
                    "肺癌",
                    "免疫药物",
                    "获批",
                    "美国",
                    "疗售价",
                    "百万"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "首款PD-1肺癌免疫药物7个月获批，美国一年疗售价百万",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]